Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach

Laboratories are increasingly requested to perform CYP2C19 genetic testing when managing clopidogrel therapy, especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. To ensure high quality molecular testing and ascertain that the referring clinician has the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Guigao, Yi, Lang, Zhang, Kuo, Wang, Lunan, Zhang, Rui, Xie, Jiehong, Li, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517881/
https://www.ncbi.nlm.nih.gov/pubmed/26218263
http://dx.doi.org/10.1371/journal.pone.0134174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517881/
https://www.ncbi.nlm.nih.gov/pubmed/26218263
http://dx.doi.org/10.1371/journal.pone.0134174

Ejemplares similares